NCT01849185

Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Meir Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective is to examine whether probiotics given to hypercholesterolemic patients treated with statins, would further decrease LDL-Cholesterol levels. The secondary objective is to examine whether adding of probiotics to statins would decrease fasting glucose levels and glycolysated hemoglobin

Conditions

• Hypercholesterolemia

Interventions

Type	Name	Description
OTHER	Food supplement

Timeline

• Start date: 2013-05-01
• Primary completion: 2014-01-01
• Completion: 2014-03-01
• First posted: 2013-05-08
• Last updated: 2013-05-08

Locations

1 site across 1 country: Israel